acrolein has been researched along with Diabetes, Gestational in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Moneim, A; AbdElgawad, H; Abdul-Hamid, M; Beemster, GTS; El-Twab, SA; Hosni, A; Prinsen, E | 1 |
| Abdel-Moneim, AA; Abdel-Reheim, ES; Helmy, H; Hosni, AA; Mohamed, SM | 1 |
2 other study(ies) available for acrolein and Diabetes, Gestational
| Article | Year |
|---|---|
Cinnamaldehyde mitigates placental vascular dysfunction of gestational diabetes and protects from the associated fetal hypoxia by modulating placental angiogenesis, metabolic activity and oxidative stress.
Topics: Acrolein; Animals; Blood Glucose; Diabetes, Gestational; Energy Metabolism; Female; Fetal Hypoxia; Neovascularization, Pathologic; Oxidative Stress; Placenta; Pregnancy; Rats; Rats, Wistar | 2021 |
Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPARĪ³, proinflammatory cytokines and oxidative stress.
Topics: Acrolein; Adipose Tissue; Animals; Antioxidants; Biomarkers; Blood Glucose; Body Weight; Cholesterol; Cytokines; Diabetes, Gestational; Feeding Behavior; Female; Fetus; Fructosamine; Glucose Tolerance Test; Glycogen; Hyperglycemia; Inflammation Mediators; Insulin; Leptin; Liver; Oxidative Stress; PPAR gamma; Pregnancy; Pregnancy Outcome; Rats; RNA, Messenger; Triglycerides | 2017 |